Neurones Stock

Neurones EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurones (NRO.PA) as of Aug 5, 2026 is 72.33 M EUR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 95.10 M EUR — a change of -23.95% (lower).

EBITDA

72.33 MEUR

YoY

-23.95%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurones is 2026 72.33 M EUR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurones was 2025 95.10 M EUR. It decreases by -23.95% lower compared to the previous year.
Access this data via the Eulerpool API

Neurones Stock analysis

What does Neurones do? Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurones stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurones is 72.33 M EUR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Neurones changed from 95.10 M EUR to 72.33 M EUR, representing a -23.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Neurones since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Neurones historically and in real time.

Access this data via the Eulerpool API

Income Statement — Neurones

All Key Metrics — Neurones